Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18200488 | 0.93 | ESR1 (0.38) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200979 | 0.92 | ESR1 (0.42) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200643 | 0.91 | LMNA (0.45) | ESR1ESR2LMNAADORA2ANUDT1 | |
| SCHEMBL18200604 | 0.90 | ESR1 (0.42) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18201033 | 0.90 | ESR1 (0.42) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200538 | 0.90 | ESR1 (0.42) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200645 | 0.90 | MAPK8 (0.43) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200990 | 0.89 | ESR1 (0.40) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200633 | 0.88 | MAPK8 (0.42) | ESR1ESR2MAPK8MAPK9MAPK10 | |
| SCHEMBL18200972 | 0.87 | ESR1 (0.45) | ESR1ESR2LMNAADORA2ANUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-20170179402-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179402-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2016-12-29 | — | — | US | disclosed |
| EP-3088392-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Heesung Material Ltd. (KR) | 2016-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | NOTUM, DDT, CRY1 | ESR1 207/4885ESR2 1442/4885MAPK8 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.